Navigation Links
Ariel Way's GovBuys Awarded VA Contract
Date:4/28/2011

WASHINGTON, April 28, 2011 /PRNewswire/ -- Ariel Way, Inc., (PK: AWYI) www.arielway.com, today announced that its subsidiary Government-Buys, Inc. ("GovBuys") has been awarded a contract with Department of Veterans Affairs ("VA") for Robotic Telepathology Equipment for the VHA Telepathology Pilot Program.

GovBuys will provide for the VHA Telepathology pilot program, together with its subcontractor Apollo PACS of Falls Church, VA, robotic telepathology systems consisting of robotic microscopes, robotic stages, objectives, digital cameras and computers. GovBuys will also provide installation, warranty, ongoing maintenance and technical support for the equipment deployed. The system will initially be installed at 10 different VA facilities nationwide. The value of the contract for the initial installation is $788,525.

Gary Block, Ariel Way Executive Vice President said, "We are very excited about the VA contract that we were awarded in competition with other firms and we are very pleased to work with our partners at Apollo PACS. We hope this could be the beginning of a large-scale deployment to all 167 VA facilities. We also hope this could open up additional opportunities within the Department of Defense, e.g."

Government-Buys, Inc., (www.govbuys.com) is a Bethesda, Maryland based small business ("GovBuys") within the Ariel Way group of companies that specializes in facilitating transactions between government agencies, industry partners and contractors, employing a wide array of contract vehicles and strategies to ensure a timely and efficient procurement. Contractor partners include a number of small businesses, small disadvantaged, 8(a), Service-disabled, Native American and Alaskan Native owned firms. Contract vehicles include GSA 8(a) STARS, GSA Schedule (Group 70), DAR BPA, and a variety of organization-specific Blanket Purchase Agreements.

About Ariel Way, Inc.

Ariel Way, Inc., a Florida corporation ("Ariel Way" or the "Company"), is a technology and services company for highly secure global communications, multimedia and digital signage solutions and technologies. The Company is focused on developing innovative and secure technologies, acquiring and growing profitable advanced technology companies and global communications service providers and creating strategic alliances with companies in complementary product lines and service industries.

More information about Ariel Way can be found on the web at http://www.arielway.com.

Forward-Looking Statements: Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements," which are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. See the Company's latest Form 10-KSB for a discussion of such risks, uncertainties and other factors. Any forward-looking statements are made pursuant to the Private Securities Litigation Reform Act of 1995 and, as such, speak only as of the date made. These forward-looking statements are based on management's expectations as of the date hereof, and the Company does not undertake any responsibility to update any of these statements in the future.


'/>"/>
SOURCE Ariel Way, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PCMA: Generics, Mail-Service Pharmacy Recognized as Ways to Reduce Costs for TRICARE Program
2. CVS/pharmacy Helps Seniors Evaluate Medicare Part D Options and Identify Potential Ways to Save on Prescription Drugs in 2011
3. D3 Launches New Suite of Solutions, including the First Radiation Oncology Clinical Pathways Program, at the ASTRO Annual Meeting, October 31 - November 3, 2010 in San Diego
4. CVS Caremark Maintenance Choice Program Improves Medication Adherence for US Airways Employees and Dependents
5. Bionovo Announces Publication Describing Menerbas Effect on Neural Pathways Related to Temperature Regulation
6. CSafe Signs Master Lease With Cathay Pacific Airways to Further Enhance Healthcare and Pharmaceutical Transport
7. Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum
8. ADIN Healthcare Identifies the Top Six Ways Employers Lose Money on Diagnostic Testing for Workplace Injuries
9. Experience Not Always the Best Prescription for Snowblowers
10. Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate for Cancer Treatment
11. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... Research and Markets has announced the addition of the "Contraceptives - ... ... the US, Canada , Japan , ... Latin America , and Rest of World. Annual estimates and forecasts ... analysis is provided for these markets. Market data and analytics are derived ...
(Date:2/17/2017)... 2017  Ethicon, Inc. today announced a definitive ... held medical device company that manufactures and markets ... novel minimally invasive device for the surgical treatment ... enable Ethicon to offer patients a safe and ... surgical procedure. 1 This LINX ...
(Date:2/17/2017)... Theravance Biopharma, Inc. (NASDAQ: ... announced the presentation of positive clinical data for ... kinase (JAK) inhibitor designed to be intestinally restricted, ... European Crohn,s and Colitis Organization (ECCO). In a ... its completed Phase 1 study of single-ascending and ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... While EHR data has revolutionized ... an innovative workstation designed to reduce nursing fatigue while enhancing productivity. Based on ... offers a lightweight, highly mobile, multi-functional alternative to the limitations of handheld computing. ...
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... software tools that allow for the electronic prescribing of controlled and non-controlled substances ... , Ninety percent of pharmacies in the United States now accept electronic prescriptions, ...
(Date:2/17/2017)... (PRWEB) , ... February 17, ... ... Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. 22, 2017 — ... are the critical reimbursement questions manufacturers should be asking before selecting an ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 — 1:30 p.m. – ... between corrective action (CA) and preventive action (PA)? , The methods share techniques ...
(Date:2/17/2017)... Springs, Texas (PRWEB) , ... February 17, 2017 ... ... Signature 8.0 at the HIMSS17 Conference & Exhibition in Orlando, Fla., February 19-23. ... latest version of the most widely used electronic patient signatures solution in ...
Breaking Medicine News(10 mins):